APA (7th ed.) Citation

Liu, L., Wang, E., Li, L., Chen, D., Peng, K., Wang, M., & Han, G. As Clinical Markers, Hand-Foot-Skin Reaction and Diarrhea Can Predict Better Outcomes for Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization plus Sorafenib. Wiley.

Chicago Style (17th ed.) Citation

Liu, Lei, Enxin Wang, Lin Li, Dongyu Chen, Kun Peng, Mengmeng Wang, and Guohong Han. As Clinical Markers, Hand-Foot-Skin Reaction and Diarrhea Can Predict Better Outcomes for Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization Plus Sorafenib. Wiley.

MLA (9th ed.) Citation

Liu, Lei, et al. As Clinical Markers, Hand-Foot-Skin Reaction and Diarrhea Can Predict Better Outcomes for Hepatocellular Carcinoma Patients Receiving Transarterial Chemoembolization Plus Sorafenib. Wiley.